Janus Henderson Group’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Buy |
69,479
+47,879
| +222% | +$835K | ﹤0.01% | 1521 |
|
|
2025
Q1 | $270K | Hold |
21,600
| – | – | ﹤0.01% | 2246 |
|
|
2024
Q4 | $228K | Hold |
21,600
| – | – | ﹤0.01% | 2374 |
|
|
2024
Q3 | $313K | Hold |
21,600
| – | – | ﹤0.01% | 2246 |
|
|
2024
Q2 | $183K | Sell |
21,600
-213
| -1% | -$1.81K | ﹤0.01% | 2415 |
|
|
2024
Q1 | $223K | Buy |
21,813
+4
| +0% | +$41 | ﹤0.01% | 2375 |
|
|
2023
Q4 | $120K | Sell |
21,809
-74
| -0.3% | -$406 | ﹤0.01% | 2513 |
|
|
2023
Q3 | $82.9K | Buy |
21,883
+4
| +0% | +$15 | ﹤0.01% | 2533 |
|
|
2023
Q2 | $147K | Buy |
+21,879
| New | +$147K | ﹤0.01% | 2522 |
|